San Diego-primarily based Viking Therapeutics marked itself as a serious competitor within the weight loss drug industry in February right after revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when presented as a weekly injection and in March t